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With the economy globalization ,corporate governance is getting more and more 
attention all over the world, corporate governance now is one of the most concerning 
problems  for Chinese companies. Perfect corporate governance is the micro-base for 
healthy operation of modern market-oriented economy and security market. It is of 
great significance for economy and finance stability and development. Because of key 
status of the supervisory board, the mend of the internal structure and the operation of 
the supervisory board, and the improvement of the company’s performance, become 
the crucial task of setting up an effective administration structure of supervisory 
board. 
We will take the 102 medicine A-share listed companies (2005) in our country as 
samples, mainly focus on three respects of the management of the supervisory board 
in our country: namely the management of the internal structure of supervisory board; 
the management of the operation of the supervisory board; the management of the 
supervisory board and the performance of the company.  
This paper adopts ROE, ROA, EPS and Tobbin’s Q to measure corporate 
performance and analyze the relationship between the board characteristic and 
corporate performance. Results show that the size of the board is uncorrelated with 
firm performance; the frequency of the board meeting is uncorrelated with firm 
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